Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Link
http://www.nature.com/articles/cddis2015217.pdf
Reference43 articles.
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ . Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225–249.
2. Somaiah N, Simon NG, Simon GR . A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer. J Thorac Oncol 2012; 7: S342–S368.
3. Vari S, Pilotto S, Maugeri-Sacca M, Ciuffreda L, Cesta Incani U, Falcone I et al. Advances towards the design and development of personalized non-small-cell lung cancer drug therapy. Expert Opin Drug Discov 2013; 8: 1381–1397.
4. Li T, Kung HJ, Mack PC, Gandara DR . Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol 2013; 31: 1039–1049.
5. Cagle PT, Chirieac LR . Advances in treatment of lung cancer with targeted therapy. Arch Pathol Lab Med 2012; 136: 504–509.
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring the Role of Unconventional Post-Translational Modifications in Cancer Diagnostics and Therapy;Current Protein & Peptide Science;2024-12
2. In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb;Frontiers in Pharmacology;2024-07-01
3. ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity;Frontiers in Immunology;2024-02-02
4. The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases;Molecular Biomedicine;2024-01-04
5. Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia;Biomedicine & Pharmacotherapy;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3